Amyloid-beta peptide biomarker_for Alzheimer’s disease

Subject: Amyloid-beta peptide
Relation: biomarker_for
Object: Alzheimer’s disease
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility. (2018) PMID:30297968 cited

subjects displayed a range of amyloid-β ... with 60% having a pathologic diagnosis of Alzheimer’s disease

confidence: 0.90